Kalinox 170 Bar

Nitrous oxide, the active ingredient in Kalinox 170 Bar, is a analgesic, anesthetic gas presented as a gas mixture for inhalation use. It provides analgesia and sedation for minor surgical or dental procedures and diagnostic or therapeutic procedures.

GNH USA supplies Kalinox 170 Bar as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kalinox 170 Bar, a nitrous oxide/oxygen gas mixture, is used for analgesia and sedation in procedures involving the nervous system.

- Dental procedures: provides analgesia and anxiolysis during restorative or surgical dental work. - Minor surgical procedures: offers analgesic and sedative effect for minor skin or soft‑tissue surgeries. - Diagnostic/therapeutic procedures: facilitates patient comfort and reduces anxiety during endoscopic or imaging examinations.

Adverse reactions may occur with nitrous oxide/oxygen inhalation.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional emesis during or after inhalation. - Dizziness: transient light‑headedness. - Headache: mild headache during recovery. - Euphoria: brief feeling of well‑being. - Increased salivation: excess oral secretions.

Serious or Rare Side Effects: - Hypoxia: insufficient oxygen leading to cyanosis. - Respiratory depression: reduced breathing effort. - Severe hypotension: marked drop in blood pressure. - Loss of consciousness: unexpected fainting. - Seizures: rare convulsive episodes. - Allergic reaction: rash, itching, or anaphylaxis.

Before using Kalinox 170 Bar, consider the following safety measures.

- Assess respiratory function: ensure the patient can maintain airway patency. - Evaluate cardiovascular status: monitor blood pressure and heart rate. - Avoid use in severe COPD or obstructive lung disease. - Use caution in pregnancy: fetal safety not established. - Ensure proper scavenging: limit occupational exposure to waste gas. - Store at ambient temperature: keep cylinder in original container, protect from heat and direct sunlight.

Nitrous oxide/oxygen may interact with other substances.

Major Interactions (Avoid): - Central nervous system depressants: concurrent opioids or benzodiazepines may cause profound respiratory depression. - Volatile anesthetics: combined use can increase risk of hypotension. - Methoxyflurane: co‑administration may enhance nephrotoxicity.

Moderate Interactions (Monitor Closely): - MAO inhibitors: may intensify sedation. - Alcohol: can increase dizziness and impairment. - Certain antidepressants: may alter the depth of sedation.